Your search returned 86 results.

Results
	81.	Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma. [electronic resource] by Limat, S Daguindau, E Cahn, J-Y Nerich, V Brion, A Perrin, S Woronoff-Lemsi, M-C Deconinck, E Producer: 20141106 In: Journal of clinical pharmacy and therapeutics vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	82.	Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. [electronic resource] by Ichikawa, Yoshihiko Ghanefar, Mohsen Bayeva, Marina Wu, Rongxue Khechaduri, Arineh Naga Prasad, Sathyamangla V Mutharasan, R Kannan Naik, Tejaswitha Jairaj Ardehali, Hossein Producer: 20140407 In: The Journal of clinical investigation vol. 124 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	83.	Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells. [electronic resource] by Smith, Tim A D Phyu, Su M Akabuogu, Emmanuel U Producer: 20160503 In: Anticancer research vol. 36 Availability: No items available. Save to lists Add to cart (remove)
	84.	Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors. [electronic resource] by Lipshultz, Steven E Anderson, Lynn M Miller, Tracie L Gerschenson, Mariana Stevenson, Kristen E Neuberg, Donna S Franco, Vivian I LiButti, Daniel E Silverman, Lewis B Vrooman, Lynda M Sallan, Stephen E Producer: 20160726 In: Cancer vol. 122 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	85.	Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia. [electronic resource] by Krajinovic, M Elbared, J Drouin, S Bertout, L Rezgui, A Ansari, M Raboisson, M-J Lipshultz, S E Silverman, L B Sallan, S E Neuberg, D S Kutok, J L Laverdière, C Sinnett, D Andelfinger, G Producer: 20170808 In: The pharmacogenomics journal vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	86.	The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells. [electronic resource] by Deng, Shiwei Yan, Tiandong Nikolova, Teodora Fuhrmann, Dominik Nemecek, Andrea Gödtel-Armbrust, Ute Kaina, Bernd Wojnowski, Leszek Producer: 20160105 In: British journal of pharmacology vol. 172 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5